May 23 2011
Phytoceuticals Ltd. will present promising clinical and scientific data on 1 PRIMARY WOUND DRESSING® (www.1wound.com) at the 2011 EWMA Conference on May 26, the largest European wound management conference.
“Furthermore '1' has an antimicrobial effect and promotes the regeneration of the epidermis. These effects clearly make'1' a modern and convincing wound product of your first choice.”
The data underlines the product's first choice positioning and effective mode of action. "1" is the first product of the Company's wound care platform that is being commercialized.
"I am excited about the clinical results. The extensive indication range, simple application form and convincing mode of action make '1' a truly unique product in the crowded wound care industry, said Chairman Dr. Stephan Rietiker, M.D.. "We have started to directly promote the product in Switzerland, our home market," added CEO Eduardo Theiler. "Given the convincing data we now feel confident to expand throughout Europe, ideally together with a strong industry partner."
Pyroptosis found to promote wound healing and tissue repair